BLBP expression has been correlated with poor clinical outcome in several aggressive forms of cancer, such as renal cancer [22], hepatocellular carcinoma [30] and aggressive triple-negative breast cancer [31]. Here, FABP7 is linked to hepatocellular carcinoma.